{{lowercase}}
{{PBB|geneid=3458}}
{{Infobox protein family
| Symbol = 
| Name = IFN-γ
| image = PDB 1eku EBI.jpg
| width = 
| caption = Crystal structure of a biologically active single chain mutant of human interferon gamma
| Pfam = PF00714
| Pfam_clan = CL0053 
| InterPro = IPR002069
| SMART = 
| PROSITE = 
| MEROPS = 
| SCOP = 1rfb
| TCDB = 
| OPM family = 
| OPM protein = 
| CAZy = 
| CDD = 
}}
{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 458270952
| IUPAC_name = Human interferon gamma-1b

<!--Clinical data -->
| tradename =  Actimmune
| Drugs.com = {{drugs.com|monograph|interferon-gamma}}
| MedlinePlus = a601152
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B / C / D / X -->
| legal_AU = <!-- Unscheduled / S2 / S4 / S8 -->
| legal_UK = <!-- GSL / P / POM / CD -->
| legal_US = <!-- OTC / Rx-only -->

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 82115-62-6
| CAS_number2 = 98059-61-1
| ATC_prefix = L03
| ATC_suffix = AB03
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB00033
| ChEMBL_Ref = {{ebicite|changed|EBI}}
| ChEMBL = 1201564
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = NA

<!--Chemical data-->
| C=761 | H=1206 | N=214 | O=225 | S=6 
| molecular_weight = 17145.6 g/mol
}}

'''干扰素-γ'''（Interferon gamma、Interferon-γ、IFNG、IFNγ）是[[水溶性|水溶性]][[二聚体|二聚体]]的[[细胞因子|细胞因子]]<ref>Gray PW, Goeddel DV. Structure of the human immune interferon gene. Nature. 1982 Aug 26;298(5877):859-63.</ref>。是II型干扰素的唯一成员<ref name="pmid6180322">{{cite journal | author = Gray PW, Goeddel DV | title = Structure of the human immune interferon gene | journal = Nature | volume = 298 | issue = 5877 | pages = 859–63 | date = August 1982 | pmid = 6180322 | doi = 10.1038/298859a0 | url =  }}</ref>曾被称为'''巨噬细胞活化因子'''。

== 结构== 
[[干扰素|干扰素]][[伽玛蛋白|伽玛蛋白]]的[[单体|单体]]是由六个α螺旋组成一个核心<ref>Ealick SE, et al., Three-dimensional structure of recombinant human interferon-gamma. Science. 1991 May 3;252(5006):698-702.</ref>和在C端区延伸展开的片断序列。

生物活性的[[二聚体|二聚体]]是由两个反平行相互锁定的[[单体|单体]]形成。

== 生物活性 ==
所有的细胞都可以产生{{le|干扰素-α|Interferon alfa}}和[[干扰素-β|干扰素-β]]， 而干扰素伽玛只由活化[[T细胞|T细胞]]和[[自然杀伤细胞|自然杀伤细胞]]（NK细胞）产生。  在血清学上，I型干扰素是酸稳定， 而干扰素伽玛则遇酸变性。

干扰素伽玛具有抗病毒、免疫调节及抗肿瘤特性<ref>Schroder K, Hertzog PJ,  Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions.  J Leukoc Biol. 2004 Feb;75(2):163-89.</ref>。可以与结合到{{le|干扰素伽玛受体|Interferon-gamma receptor}}(IFNGR)，干扰素伽玛受体由两个[[蛋白质亚基|亚基]]组成。干扰素伽玛结合激活其受体调节[[JAK-STAT通路|JAK-STAT通路]]。干扰素伽玛激活[[抗原提呈细胞|抗原提呈细胞]]，通过上调[[转录因子|转录因子]]T-bet而促进I型辅助T细胞(Th1细胞)的分化。

干扰素伽玛是[[輔助型T細胞#TH1輔助細胞|I型辅助T细胞]](Th1细胞)的标志性的细胞因子。[[輔助型T細胞#TH2輔助細胞|II型辅助T细胞]](Th2细胞)释放[[白细胞介素-4|白细胞介素-4]]（IL-4）和白细胞介素-13（IL-13）。[[自然杀伤细胞|自然杀伤细胞]]和CD8<sup>+</sup>T细胞也产生干扰素伽玛。干扰素伽玛通过迅速降解RANK-RANKL信号通路的TRAF6而抑制[[破骨细胞|破骨细胞]]形成。

== 治疗用途 ==
干扰素可以用来治疗[[传染病|传染病]]，但也能促成[[自體免疫|自體免疫]]。在接受干扰素伽玛治疗的病人中，多达19%的病人会有自體免疫.

干擾素IFNγ用於豬生殖與呼吸道綜合症PRRSV的治療上，有試驗發現干擾素IFNγ能活化先天免疫細胞，進而達到抑制病毒數量的效果。<ref>{{Cite journal|title=IFNγ inhibits porcine reproductive and respiratory syndrome virus replication in macrophages|url=http://dx.doi.org/10.1007/s007050050578|last=Bautista|first=E. M.|last2=Molitor|first2=T. W.|date=1999-06|journal=Archives of Virology|issue=6|doi=10.1007/s007050050578|volume=144|pages=1191–1200|issn=0304-8608}}</ref>

A型流感的治療上，也有小鼠試驗表現出當缺失干擾素後，流感感染小鼠死亡率大幅提升且體內病毒數量維持高濃度水平；相較之下，體內有干擾素存在的小鼠，流感病毒數量隨著干擾素的生成而逐漸下降。<ref>{{Cite journal|title=Effect of anti-interferon serum of influenza virus infection in mice|url=http://dx.doi.org/10.1016/0166-3542(83)90015-3|last=Hoshino|first=Akinori|last2=Takenaka|first2=Hiroshi|date=1983-03|journal=Antiviral Research|issue=1|doi=10.1016/0166-3542(83)90015-3|volume=3|pages=59–65|issn=0166-3542|last3=Mizukoshi|first3=Osamu|last4=Imanishi|first4=Jiro|last5=Kishida|first5=Tsunataro|last6=Tovey|first6=Michael G.}}</ref>

== 参考文献 ==
{{reflist|2}}
== 延伸閱讀 ==
{{refbegin|2}}
* {{cite book | author = Hall, Stephen K. | authorlink = | editor = | others = | title = A commotion in the blood: life, death, and the immune system | edition = | language = | publisher = Henry Holt | location = New York | year = 1997 | origyear = | pages = | quote = | isbn = 0-8050-5841-9 | oclc = | doi = | url =https://archive.org/details/commotioninblood00hall| accessdate = }}
*{{cite journal | author = Ikeda H, Old LJ, Schreiber RD | title = The roles of IFN gamma in protection against tumor development and cancer immunoediting. | journal = Cytokine Growth Factor Rev. | volume = 13 | issue = 2 | pages = 95–109 | year = 2002 | pmid = 11900986 | doi = 10.1016/S1359-6101(01)00038-7 }}
*{{cite journal | author = Chesler DA, Reiss CS | title = The role of IFN-gamma in immune responses to viral infections of the central nervous system. | journal = Cytokine Growth Factor Rev. | volume = 13 | issue = 6 | pages = 441–54 | year = 2003 | pmid = 12401479 | doi = 10.1016/S1359-6101(02)00044-8 }}
*{{cite journal | author = Dessein A, Kouriba B, Eboumbou C, Dessein H, Argiro L, Marquet S, Elwali NE, Rodrigues V, Li Y, Doumbo O, Chevillard C | title = Interleukin-13 in the skin and interferon-gamma in the liver are key players in immune protection in human schistosomiasis. | journal = Immunol. Rev. | volume = 201 | issue =  | pages = 180–90 | year = 2005 | pmid = 15361241 | doi = 10.1111/j.0105-2896.2004.00195.x }}
*{{cite journal | author = Joseph AM, Kumar M, Mitra D | title = Nef: "necessary and enforcing factor" in HIV infection. | journal = Curr. HIV Res. | volume = 3 | issue = 1 | pages = 87–94 | year = 2005 | pmid = 15638726 | doi = 10.2174/1570162052773013 }}
*{{cite journal | author = Copeland KF | title = Modulation of HIV-1 transcription by cytokines and chemokines. | journal = Mini reviews in medicinal chemistry | volume = 5 | issue = 12 | pages = 1093–101 | year = 2006 | pmid = 16375755 | doi = 10.2174/138955705774933383 }}
*{{cite journal | author = Chiba H, Kojima T, Osanai M, Sawada N | title = The significance of interferon-gamma-triggered internalization of tight-junction proteins in inflammatory bowel disease. | journal = Sci. STKE | volume = 2006 | issue = 316 | pages = pe1 | year = 2006 | pmid = 16391178 | doi = 10.1126/stke.3162006pe1 }}
*{{cite journal | author = Tellides G, Pober JS | title = Interferon-gamma axis in graft arteriosclerosis. | journal = Circ. Res. | volume = 100 | issue = 5 | pages = 622–32 | year = 2007 | pmid = 17363708 | doi = 10.1161/01.RES.0000258861.72279.29 }}
{{refend}}

== 参看 ==
*[[T细胞|T细胞]]
*[[辅助T细胞|辅助T细胞]]
*[[II型干扰素|II型干扰素]]
*[[细胞因子|细胞因子]]

== 外部链接 ==
* [http://www.nlm.nih.gov/cgi/mesh/2007/MB_cgi?mode=&term=Interferon+Type+II MeSH|Interferon+Type+II] {{Wayback|url=http://www.nlm.nih.gov/cgi/mesh/2007/MB_cgi?mode=&term=Interferon+Type+II |date=20160310222303 }}

{{PDB Gallery|geneid=3458}}
{{Cytokine receptor modulators|state=autocollapse}}
{{细胞因子}}
{{免疫增强剂}}
{{DNA antivirals}}

[[Category:细胞因子|Category:细胞因子]]
[[Category:免疫学|Category:免疫学]]